HARD SCIENCE
Dr. Deborah Mash, a pioneering researcher and one of the world’s foremost experts on ibogaine, has extensively studied its clinical applications for over two decades. In an interview, she emphasized the transformative potential of ibogaine in addiction treatment, stating, “If ibogaine stays in the underground, back-doors, and back alleys outside of mainstream medical use, it’s never going to get out of Schedule 1 or be approved as a therapeutic drug, and we’ll never be able to get it to the millions of people who are desperate” (Psychedelic Times, 2016; Psychedelic Vantage, 2024).
Dr. Mash's research highlights that ibogaine has neuroprotective and neuroadaptive properties, which contribute to its reputation as a "reset button" for the brain, particularly in treating addiction. Her studies suggest that ibogaine, through its metabolite noribogaine, offers long-term anti-addictive effects by modulating neuroplasticity and supporting the survival of dopaminergic neurons (Psychable, 2024; Psychedelic Vantage, 2024).
These insights underscore the potential of ibogaine not only in addiction therapy but also in broader mental health applications, offering hope and a new path to recovery for many.
References:
-
Psychedelic Times. "Dr. Deborah Mash Talks About the Unique Power of Ibogaine Therapy for Drug Addiction." Available at: Psychedelic Times.
-
Psychedelic Vantage. "Dr. Deborah Mash: Ibogaine’s potential in Neuropsychiatry." Available at: Psychedelic Vantage.
-
Psychable. "Ibogaine 101: Your FAQs Answered." Available at: Psychable.
Neurogenesis
Ibogaine has been shown to stimulate the growth of new brain cells, particularly in the hippocampus, which is crucial for learning and memory. This process, known as neurogenesis, helps in the recovery of brain function in individuals who have experienced cognitive decline due to substance abuse or other neurological conditions.
How Does Ibogaine Work in the Brain? - Dr. Martin Polanco
Resetting of Dopamine System
Yes, it is true and verifiable that ibogaine modulates the dopamine system, which is often disrupted in addiction. Ibogaine affects various neurotransmitter systems, including dopamine, by acting as a non-competitive inhibitor of dopamine transporters. This action helps to reset dopamine levels and receptor densities, reducing pathological cravings and compulsive consumption patterns associated with addiction. By promoting the release of neurotrophic factors and supporting neuroplasticity, ibogaine helps in rewiring the brain's reward system, which is crucial for recovery from addiction.
Serotonin Receptor Interaction
Ibogaine interacts with serotonin receptors (specifically 5-HT2A), which are implicated in the regulation of mood and anxiety.
This interaction can lead to an antidepressant effect and may also play a role in the psychotherapeutic effects of Iboga.
NMDA Receptor Antagonism
Yes, it is true and verifiable that ibogaine acts as an NMDA receptor antagonist, which helps in decreasing excitotoxicity (neuron damage caused by excessive stimulation) in the brain. This property is particularly beneficial in preventing neurodegeneration and improving conditions like depression and addiction.
Ibogaine's antagonism of NMDA receptors contributes to its neuroprotective effects, reducing the potential for neuronal damage and promoting neural growth and repair. This modulation of glutamate levels in the brain supports the overall therapeutic benefits of ibogaine in treating addiction and mental health disorders
Sigma Receptor Agonism
By acting on sigma receptors, ibogaine may offer neuroprotective effects, reducing the stress on brain cells and promoting their survival under conditions that would normally lead to apoptosis
(programmed cell death).
NMDA Receptor Antagonism
Yes, it is true that ibogaine is an NMDA receptor antagonist, which helps in decreasing excitotoxicity (neuron damage caused by excessive stimulation) in the brain. This property is particularly beneficial in preventing neurodegeneration and improving conditions like depression and addiction. By blocking NMDA receptors, ibogaine can help protect neurons from damage and promote neural health, contributing to its therapeutic effects in treating addiction and other mental health disorders.
Enhancement of Executive Functioning
By improving prefrontal cortex activity, low doses of Iboga alkaloids might enhance executive functions such as
decision-making, problem-solving, and impulse control, which are often compromised in psychiatric conditions.
Alteration of Default Mode Network (DMN)
Iboga has the potential to alter the activity of the Default Mode Network (DMN), the brain network associated with
self- referential thoughts and mind wandering. Modulating the DMN can lead to changes in patterns of thought and behavior, often beneficial in conditions like depression.
Glial Cell Line-Derived Neurotrophic Factor (GDNF) Expression
Derived Neurotrophic Factor (GDNF), a protein that promotes the survival of neurons. Increased levels of GDNF can aid in the repair and maintenance of neural circuits, potentially alleviating symptoms of neurodegenerative diseases and conditions like addiction.
Research has shown that ibogaine administration increases GDNF expression in key brain regions involved in addiction and reward, such as the Ventral Tegmental Area (VTA) and the Substantia Nigra. This increase in GDNF supports neuron survival, growth, and differentiation, helping to repair neural damage and enhance neuroplasticity.
These neuroprotective effects are crucial for preventing neurodegeneration and improving brain function, particularly in individuals recovering from substance abuse and other neurological conditions (Frontiers) (ChemRxiv) (Blossom).
Modulation of Brain-Derived Neurotrophic Factor (BDNF)
Ibogaine has been shown to affect the levels of BDNF,
a critical growth factor that influences the health and connectivity of neurons,
crucial for learning and memory.
Discover The Incredible Power of Iboga by WAFA
Ibogaine, the active alkaloid in Iboga, has notable effects on several parts of the brain, including those involved in memory and emotional processing:
-
Prefrontal Cortex (PFC): Ibogaine can influence the activity of the prefrontal cortex, which plays a significant role in decision-making, memory, and emotional regulation. By modulating neurotransmitter systems, particularly serotonin, dopamine, and glutamate, Ibogaine may enhance cognitive function, improve emotional regulation, and potentially alleviate symptoms associated with trauma or stress-related disorders.
-
Amygdala and Ventromedial Prefrontal Cortex (vmPFC): Ibogaine is believed to modulate the amygdala's activity, which is critical in processing emotional responses, particularly fear and anxiety. The ventromedial prefrontal cortex interacts with the amygdala, and through this pathway, Ibogaine may help reduce the emotional intensity of traumatic memories, aiding in fear extinction and emotional regulation.
-
Hippocampus: The hippocampus is essential for memory formation and retrieval, particularly for long-term and traumatic memories. Ibogaine may exert neuroprotective effects and promote neuroplasticity, potentially leading to the repair or restructuring of neural circuits associated with memory and learning. This effect might help in reducing the emotional charge of traumatic memories.
-
Anterior Cingulate Cortex (ACC): Ibogaine's impact on the ACC is less well-documented, but its overall effects on emotional regulation and stress responses suggest it may influence this region. The ACC's role in pain processing and emotional regulation makes it a relevant target for Ibogaine's therapeutic potential, particularly in addressing anxiety and depression.
-
Dopaminergic and Serotonergic Systems: Ibogaine is known to affect the brain's dopamine and serotonin systems, which are intricately linked to mood, emotion, and cognitive function. By modulating these neurotransmitters, Ibogaine could potentially alleviate symptoms of depression, anxiety, and PTSD, and improve overall mental health.
Summary:
Yes, the information is accurate and can be substantiated. Ibogaine, an alkaloid derived from the Iboga plant, interacts with multiple neurotransmitter systems, including dopamine and serotonin, which are crucial in the brain's reward and mood regulation pathways. This interaction helps reduce cravings and withdrawal symptoms, making ibogaine an effective aid in addiction treatment.
Additionally, ibogaine promotes neurogenesis by increasing the expression of neurotrophic factors like GDNF and BDNF, which support the survival, growth, and maintenance of neurons, thus offering neuroprotective effects and reducing neuroinflammation.
Furthermore, ibogaine can modulate the Default Mode Network (DMN) in the brain, which is associated with self-referential thoughts and mind wandering. This modulation can lead to changes in patterns of thought and behavior, which are often beneficial for conditions like depression. By altering the activity of the DMN, ibogaine helps disrupt negative thought patterns and promotes a more adaptive and positive cognitive state (Psychable) (New Roots Ibogaine) (Concussion Alliance).